HEADER MEMBRANE PROTEIN 04-JUN-23 8T1W TITLE CRYSTAL STRUCTURE OF ORPHAN G PROTEIN-COUPLED RECEPTOR 6 WITH BOUND TITLE 2 CVN424 COMPND MOL_ID: 1; COMPND 2 MOLECULE: G-PROTEIN COUPLED RECEPTOR 6, SOLUBLE CYTOCHROME B562 COMPND 3 CHIMERA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: SPHINGOSINE 1-PHOSPHATE RECEPTOR GPR6,CYTOCHROME B-562; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: GPR6, CYBC; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ORPHAN GPCR, GPR6, BRIL, CVN424, INVERSE AGONIST, LCP, SYNCHROTRON, KEYWDS 2 APS, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.BAREKATAIN,L.JOHANSSON,J.H.LAM,A.V.SADYBEKOV,G.W.HAN,P.POPOV, AUTHOR 2 J.RUSSO,J.BLIESATH,N.BRICE,M.BERESFORD,L.CARLSON,K.S.SAIKATENDU, AUTHOR 3 H.SUN,S.MURPHY,H.MONENSCHEIN,H.H.SCHIFFER,C.LUTOMSKI,C.V.ROBINSON, AUTHOR 4 Z.LIU,T.HUA,V.KATRITCH,V.CHEREZOV REVDAT 2 18-DEC-24 8T1W 1 JRNL REMARK REVDAT 1 04-DEC-24 8T1W 0 JRNL AUTH M.BAREKATAIN,L.C.JOHANSSON,J.H.LAM,H.CHANG,A.V.SADYBEKOV, JRNL AUTH 2 G.W.HAN,J.RUSSO,J.BLIESATH,N.L.BRICE,M.B.L.CARLTON, JRNL AUTH 3 K.S.SAIKATENDU,H.SUN,S.T.MURPHY,H.MONENSCHEIN,H.H.SCHIFFER, JRNL AUTH 4 P.POPOV,C.A.LUTOMSKI,C.V.ROBINSON,Z.J.LIU,T.HUA,V.KATRITCH, JRNL AUTH 5 V.CHEREZOV JRNL TITL STRUCTURAL INSIGHTS INTO THE HIGH BASAL ACTIVITY AND INVERSE JRNL TITL 2 AGONISM OF THE ORPHAN RECEPTOR GPR6 IMPLICATED IN JRNL TITL 3 PARKINSON'S DISEASE. JRNL REF SCI.SIGNAL. V. 17 O8741 2024 JRNL REFN ESSN 1937-9145 JRNL PMID 39626010 JRNL DOI 10.1126/SCISIGNAL.ADO8741 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 7814 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.293 REMARK 3 R VALUE (WORKING SET) : 0.291 REMARK 3 FREE R VALUE : 0.322 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.290 REMARK 3 FREE R VALUE TEST SET COUNT : 413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.0700 - 5.0400 0.96 2578 138 0.2686 0.2842 REMARK 3 2 5.0400 - 3.5600 0.98 2446 143 0.3175 0.3713 REMARK 3 3 3.5600 - 3.4900 0.95 2377 132 0.3659 0.4236 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.680 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 43.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2714 REMARK 3 ANGLE : 0.634 3732 REMARK 3 CHIRALITY : 0.034 467 REMARK 3 PLANARITY : 0.005 463 REMARK 3 DIHEDRAL : 11.643 894 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8T1W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000275044. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 123 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7983 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.490 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.56 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.89000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NACH3COO, PEG 400, NACL, PPG P40, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 167.28800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 83.64400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 83.64400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 167.28800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 21 REMARK 465 LYS A 22 REMARK 465 THR A 23 REMARK 465 ILE A 24 REMARK 465 ILE A 25 REMARK 465 ALA A 26 REMARK 465 LEU A 27 REMARK 465 SER A 28 REMARK 465 TYR A 29 REMARK 465 ILE A 30 REMARK 465 PHE A 31 REMARK 465 CYS A 32 REMARK 465 LEU A 33 REMARK 465 VAL A 34 REMARK 465 PHE A 35 REMARK 465 ALA A 36 REMARK 465 ASP A 37 REMARK 465 TYR A 38 REMARK 465 LYS A 39 REMARK 465 ASP A 40 REMARK 465 ASP A 41 REMARK 465 ASP A 42 REMARK 465 ASP A 43 REMARK 465 ALA A 44 REMARK 465 GLY A 45 REMARK 465 ARG A 46 REMARK 465 ALA A 47 REMARK 465 GLY A 48 REMARK 465 GLY A 49 REMARK 465 ALA A 50 REMARK 465 ASN A 51 REMARK 465 GLY A 52 REMARK 465 SER A 53 REMARK 465 LEU A 54 REMARK 465 GLU A 55 REMARK 465 LEU A 56 REMARK 465 SER A 57 REMARK 465 SER A 58 REMARK 465 GLN A 59 REMARK 465 LEU A 60 REMARK 465 SER A 61 REMARK 465 ALA A 62 REMARK 465 GLY A 63 REMARK 465 PRO A 64 REMARK 465 PRO A 65 REMARK 465 GLY A 66 REMARK 465 LEU A 67 REMARK 465 LEU A 68 REMARK 465 LYS A 1047 REMARK 465 LEU A 1048 REMARK 465 GLU A 1049 REMARK 465 ASP A 1050 REMARK 465 LYS A 1051 REMARK 465 SER A 1052 REMARK 465 PRO A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 PRO A 1056 REMARK 465 GLU A 1057 REMARK 465 MET A 1058 REMARK 465 LYS A 1059 REMARK 465 ASP A 1060 REMARK 465 PHE A 1061 REMARK 465 ARG A 1062 REMARK 465 PHE A 348 REMARK 465 GLN A 349 REMARK 465 SER A 350 REMARK 465 LYS A 351 REMARK 465 VAL A 352 REMARK 465 PRO A 353 REMARK 465 PHE A 354 REMARK 465 ARG A 355 REMARK 465 SER A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 465 PRO A 359 REMARK 465 SER A 360 REMARK 465 GLU A 361 REMARK 465 VAL A 362 REMARK 465 GLU A 363 REMARK 465 PHE A 364 REMARK 465 LEU A 365 REMARK 465 GLU A 366 REMARK 465 VAL A 367 REMARK 465 LEU A 368 REMARK 465 PHE A 369 REMARK 465 GLN A 370 REMARK 465 GLY A 371 REMARK 465 PRO A 372 REMARK 465 HIS A 373 REMARK 465 HIS A 374 REMARK 465 HIS A 375 REMARK 465 HIS A 376 REMARK 465 HIS A 377 REMARK 465 HIS A 378 REMARK 465 HIS A 379 REMARK 465 HIS A 380 REMARK 465 HIS A 381 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 69 CG CD1 CD2 REMARK 470 GLN A 132 CG CD OE1 NE2 REMARK 470 LEU A 134 CG CD1 CD2 REMARK 470 VAL A 135 CG1 CG2 REMARK 470 LEU A 168 CG CD1 CD2 REMARK 470 TYR A 177 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 212 CG CD OE1 OE2 REMARK 470 GLU A1004 CG CD OE1 OE2 REMARK 470 LYS A1015 CG CD CE NZ REMARK 470 GLN A1025 CG CD OE1 NE2 REMARK 470 LYS A1027 CG CD CE NZ REMARK 470 GLN A1041 CG CD OE1 NE2 REMARK 470 LYS A1042 CG CD CE NZ REMARK 470 HIS A1063 CG ND1 CD2 CE1 NE2 REMARK 470 PHE A1065 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A1085 CG CD CE NZ REMARK 470 LYS A1095 CG CD CE NZ REMARK 470 TYR A1101 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A1103 CG CD OE1 NE2 REMARK 470 LYS A1104 CG CD CE NZ REMARK 470 ARG A 275 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 276 CG CD CE NZ REMARK 470 TYR A 312 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 338 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 344 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 172 79.19 -159.17 REMARK 500 LEU A 210 33.95 -94.60 REMARK 500 PRO A 221 46.18 -93.31 REMARK 500 HIS A 304 -4.33 70.08 REMARK 500 REMARK 500 REMARK: NULL DBREF 8T1W A 48 256 UNP P46095 GPR6_HUMAN 48 256 DBREF 8T1W A 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 8T1W A 270 362 UNP P46095 GPR6_HUMAN 270 362 SEQADV 8T1W MET A 21 UNP P46095 INITIATING METHIONINE SEQADV 8T1W LYS A 22 UNP P46095 EXPRESSION TAG SEQADV 8T1W THR A 23 UNP P46095 EXPRESSION TAG SEQADV 8T1W ILE A 24 UNP P46095 EXPRESSION TAG SEQADV 8T1W ILE A 25 UNP P46095 EXPRESSION TAG SEQADV 8T1W ALA A 26 UNP P46095 EXPRESSION TAG SEQADV 8T1W LEU A 27 UNP P46095 EXPRESSION TAG SEQADV 8T1W SER A 28 UNP P46095 EXPRESSION TAG SEQADV 8T1W TYR A 29 UNP P46095 EXPRESSION TAG SEQADV 8T1W ILE A 30 UNP P46095 EXPRESSION TAG SEQADV 8T1W PHE A 31 UNP P46095 EXPRESSION TAG SEQADV 8T1W CYS A 32 UNP P46095 EXPRESSION TAG SEQADV 8T1W LEU A 33 UNP P46095 EXPRESSION TAG SEQADV 8T1W VAL A 34 UNP P46095 EXPRESSION TAG SEQADV 8T1W PHE A 35 UNP P46095 EXPRESSION TAG SEQADV 8T1W ALA A 36 UNP P46095 EXPRESSION TAG SEQADV 8T1W ASP A 37 UNP P46095 EXPRESSION TAG SEQADV 8T1W TYR A 38 UNP P46095 EXPRESSION TAG SEQADV 8T1W LYS A 39 UNP P46095 EXPRESSION TAG SEQADV 8T1W ASP A 40 UNP P46095 EXPRESSION TAG SEQADV 8T1W ASP A 41 UNP P46095 EXPRESSION TAG SEQADV 8T1W ASP A 42 UNP P46095 EXPRESSION TAG SEQADV 8T1W ASP A 43 UNP P46095 EXPRESSION TAG SEQADV 8T1W ALA A 44 UNP P46095 EXPRESSION TAG SEQADV 8T1W GLY A 45 UNP P46095 EXPRESSION TAG SEQADV 8T1W ARG A 46 UNP P46095 EXPRESSION TAG SEQADV 8T1W ALA A 47 UNP P46095 EXPRESSION TAG SEQADV 8T1W LEU A 123 UNP P46095 CYS 123 ENGINEERED MUTATION SEQADV 8T1W PRO A 173 UNP P46095 ALA 173 ENGINEERED MUTATION SEQADV 8T1W TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 8T1W ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 8T1W LEU A 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 8T1W ALA A 900 UNP P0ABE7 LINKER SEQADV 8T1W ARG A 279 UNP P46095 GLY 279 ENGINEERED MUTATION SEQADV 8T1W CYS A 291 UNP P46095 SER 291 ENGINEERED MUTATION SEQADV 8T1W LEU A 320 UNP P46095 TYR 320 ENGINEERED MUTATION SEQADV 8T1W ASP A 345 UNP P46095 CYS 345 ENGINEERED MUTATION SEQADV 8T1W GLU A 363 UNP P46095 EXPRESSION TAG SEQADV 8T1W PHE A 364 UNP P46095 EXPRESSION TAG SEQADV 8T1W LEU A 365 UNP P46095 EXPRESSION TAG SEQADV 8T1W GLU A 366 UNP P46095 EXPRESSION TAG SEQADV 8T1W VAL A 367 UNP P46095 EXPRESSION TAG SEQADV 8T1W LEU A 368 UNP P46095 EXPRESSION TAG SEQADV 8T1W PHE A 369 UNP P46095 EXPRESSION TAG SEQADV 8T1W GLN A 370 UNP P46095 EXPRESSION TAG SEQADV 8T1W GLY A 371 UNP P46095 EXPRESSION TAG SEQADV 8T1W PRO A 372 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 373 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 374 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 375 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 376 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 377 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 378 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 379 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 380 UNP P46095 EXPRESSION TAG SEQADV 8T1W HIS A 381 UNP P46095 EXPRESSION TAG SEQRES 1 A 455 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 455 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP ALA GLY ARG SEQRES 3 A 455 ALA GLY GLY ALA ASN GLY SER LEU GLU LEU SER SER GLN SEQRES 4 A 455 LEU SER ALA GLY PRO PRO GLY LEU LEU LEU PRO ALA VAL SEQRES 5 A 455 ASN PRO TRP ASP VAL LEU LEU CYS VAL SER GLY THR VAL SEQRES 6 A 455 ILE ALA GLY GLU ASN ALA LEU VAL VAL ALA LEU ILE ALA SEQRES 7 A 455 SER THR PRO ALA LEU ARG THR PRO MET PHE VAL LEU VAL SEQRES 8 A 455 GLY SER LEU ALA THR ALA ASP LEU LEU ALA GLY LEU GLY SEQRES 9 A 455 LEU ILE LEU HIS PHE VAL PHE GLN TYR LEU VAL PRO SER SEQRES 10 A 455 GLU THR VAL SER LEU LEU THR VAL GLY PHE LEU VAL ALA SEQRES 11 A 455 SER PHE ALA ALA SER VAL SER SER LEU LEU ALA ILE THR SEQRES 12 A 455 VAL ASP ARG TYR LEU SER LEU TYR ASN PRO LEU THR TYR SEQRES 13 A 455 TYR SER ARG ARG THR LEU LEU GLY VAL HIS LEU LEU LEU SEQRES 14 A 455 ALA ALA THR TRP THR VAL SER LEU GLY LEU GLY LEU LEU SEQRES 15 A 455 PRO VAL LEU GLY TRP ASN CYS LEU ALA GLU ARG ALA ALA SEQRES 16 A 455 CYS SER VAL VAL ARG PRO LEU ALA ARG SER HIS VAL ALA SEQRES 17 A 455 LEU LEU SER ALA ALA PHE PHE MET VAL PHE GLY ILE MET SEQRES 18 A 455 LEU HIS LEU TYR VAL ARG ILE CYS GLN VAL VAL TRP ARG SEQRES 19 A 455 HIS ALA ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN SEQRES 20 A 455 ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA SEQRES 21 A 455 GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA SEQRES 22 A 455 LEU ASP ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP SEQRES 23 A 455 LYS SER PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS SEQRES 24 A 455 GLY PHE ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU SEQRES 25 A 455 LYS LEU ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA SEQRES 26 A 455 ALA ALA GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE SEQRES 27 A 455 GLN LYS TYR LEU ALA HIS LEU ALA ALA THR ARG LYS GLY SEQRES 28 A 455 VAL ARG THR LEU ALA VAL VAL LEU GLY THR PHE GLY ALA SEQRES 29 A 455 CYS TRP LEU PRO PHE ALA ILE TYR CYS VAL VAL GLY SER SEQRES 30 A 455 HIS GLU ASP PRO ALA VAL TYR THR TYR ALA THR LEU LEU SEQRES 31 A 455 PRO ALA THR LEU ASN SER MET ILE ASN PRO ILE ILE TYR SEQRES 32 A 455 ALA PHE ARG ASN GLN GLU ILE GLN ARG ALA LEU TRP LEU SEQRES 33 A 455 LEU LEU ASP GLY CYS PHE GLN SER LYS VAL PRO PHE ARG SEQRES 34 A 455 SER ARG SER PRO SER GLU VAL GLU PHE LEU GLU VAL LEU SEQRES 35 A 455 PHE GLN GLY PRO HIS HIS HIS HIS HIS HIS HIS HIS HIS HET X7T A1201 34 HETNAM X7T 1-{2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-{[(3R)- HETNAM 2 X7T OXOLAN-3-YL]AMINO}-7,8-DIHYDROPYRIDO[3,4-B]PYRAZIN- HETNAM 3 X7T 6(5H)-YL}ETHAN-1-ONE FORMUL 2 X7T C24 H29 F2 N5 O3 HELIX 1 AA1 ALA A 71 THR A 100 1 30 HELIX 2 AA2 PRO A 101 ARG A 104 5 4 HELIX 3 AA3 THR A 105 TYR A 133 1 29 HELIX 4 AA4 SER A 137 ASN A 172 1 36 HELIX 5 AA5 TYR A 177 GLY A 206 1 30 HELIX 6 AA6 ALA A 223 LYS A 1019 1 53 HELIX 7 AA7 ASN A 1022 THR A 1044 1 23 HELIX 8 AA8 PHE A 1065 GLU A 1081 1 17 HELIX 9 AA9 LYS A 1083 GLY A 302 1 58 HELIX 10 AB1 PRO A 307 ASN A 333 1 27 HELIX 11 AB2 ASN A 333 CYS A 347 1 15 SSBOND 1 CYS A 209 CYS A 216 1555 1555 2.03 CISPEP 1 ARG A 220 PRO A 221 0 0.09 CRYST1 63.731 63.731 250.932 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015691 0.009059 0.000000 0.00000 SCALE2 0.000000 0.018118 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003985 0.00000